Qiagen N.V. (QGEN) said Monday that it has acquired Ingenuity Systems, Inc., a privately-held U.S. company that provides software solutions to efficiently and accurately analyze and interpret the biological meaning of genomic data, for $105 million in cash, subject to customary purchase price adjustments.
The acquisition of Ingenuity, which had 2012 net sales of about $20 million, was funded from existing cash reserves.
In 2013, Qiagen expects to report adjusted net sales of about $15 million from Ingenuity, which excludes fair value adjustments to acquired deferred revenue related to sales contracts executed by Ingenuity prior to the acquisition.
The deal is expected to be dilutive to full-year 2013 adjusted diluted EPS by about $0.03 per share and to 2014 adjusted diluted EPS by about $0.02 per share, and become accretive in 2015, Qiagen said.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.